Filing Flows › Amneal Pharmaceuticals (AMRX) › Operating margin
Amneal Pharmaceuticals (AMRX) operating margin by quarter
Amneal Pharmaceuticals' operating margin was 11.1% in Q3 2026 (third quarter 2026), -5.2 pts from Q2 2026. Over the last 6 quarters it ranged from 11.1% (Q3 2026) to 19.6% (Q1 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 11.1% | -5.2 pts | — |
| Q2 2026 | 16.3% | -3.3 pts | +0.9 pts |
| Q1 2026 | 19.6% | +5.9 pts | +5.2 pts |
| Q4 2025 | 13.8% | -1.6 pts | — |
| Q2 2025 | 15.4% | +0.9 pts | — |
| Q1 2025 | 14.4% | — | — |
Q3 2026 at a glance
Amneal Pharmaceuticals, Q3 2026: revenue $863M (+10% year over year), operating margin 11.1%, net earnings $12.3M, operating cash flow $98.3M. The chart follows the revenue to costs, profit and cash.
Questions
What is Amneal Pharmaceuticals' operating margin?
Amneal Pharmaceuticals' operating margin was 11.1% in Q3 2026 (third quarter 2026), -5.2 pts from Q2 2026.
How has Amneal Pharmaceuticals' operating margin changed?
Over the last 6 quarters it ranged from 11.1% (Q3 2026) to 19.6% (Q1 2026).
Q3 2026 results → · How Amneal Pharmaceuticals makes money →